Clinical Trial Update: Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL [Phase 3]

View source ↗

Summary

A Phase 3 trial is comparing sequential ponatinib and blinatumomab against chemotherapy and imatinib in newly diagnosed adult Philadelphia chromosome–positive a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Imatinib (imatinib)
• Ponatinib (ponatinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult | Phase 3 | Status: ACTIVE_NOT_RECRUITING